Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries

The Lancet Infectious Diseases
Benedikt HuttnerCHAMP consortium

Abstract

The worldwide increase in resistance to antimicrobial drugs has made reducing the unnecessary use of antibiotics a public health priority. There have been campaigns in many countries to educate the public about appropriate use of antibiotics in outpatients. By use of a comprehensive search strategy and structured interviews, we were able to identify and review the characteristics and outcomes of 22 campaigns done at a national or regional level in high-income countries between 1990 and 2007. The intensity of the campaigns varied widely, from simple internet to expensive mass-media campaigns. All but one campaign targeted the public and physicians simultaneously. Most campaigns that were formally evaluated seemed to reduce antibiotic use. The effect on resistance to antimicrobial drugs cannot be assessed accurately at present. Although the most effective interventions and potential adverse outcomes remain unclear, public campaigns can probably contribute to more careful use of antibiotics in outpatients, at least in high-prescribing countries.

References

Mar 27, 1998·JAMA : the Journal of the American Medical Association·A C NyquistM A Sande
Sep 4, 1998·BMJ : British Medical Journal·E A Belongia, B Schwartz
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Jul 25, 2000·Emerging Infectious Diseases·V FreimuthP Potter
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R GonzalesM A Sande
Mar 1, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Karl G. Kristinsson
Apr 25, 2002·Emerging Infectious Diseases·Marc Lipsitch, Matthew H Samore
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas W HennessyJay C Butler
Jun 19, 2002·JAMA : the Journal of the American Medical Association·Linda F McCaigJames M Hughes
Jun 19, 2002·JAMA : the Journal of the American Medical Association·Joseph F PerzMarie R Griffin
Oct 19, 2002·International Journal of Antimicrobial Agents·Michael A Borg, Elizabeth Anne Scicluna
Feb 15, 2003·JAMA : the Journal of the American Medical Association·Michael A SteinmanRalph Gonzales
Apr 19, 2003·Emerging Infectious Diseases·Linda F McCaigJames M Hughes
Sep 2, 2003·Pediatrics·Jonathan A FinkelsteinRichard Platt
Jan 15, 2004·The Lancet Infectious Diseases·Roger G FinchUNKNOWN International Forum on Antibiotic Resistance colloquium
Feb 13, 2004·Respiratory Medicine·David B PriceChristopher C Winchester
Apr 3, 2004·The European Journal of General Practice·Suzanne ParsonsMartin Underwood
Apr 28, 2004·Emerging Infectious Diseases·Werner C AlbrichStephan Harbarth
Apr 26, 2005·International Journal of Antimicrobial Agents·Georgia MitsiCharalambos Gogos
Jun 21, 2005·Emerging Infectious Diseases·Stephan Harbarth, Matthew H Samore
Jun 21, 2005·Emerging Infectious Diseases·Karen M KiangEdward A Belongia
Jul 22, 2005·The Journal of Antimicrobial Chemotherapy·Annemiek E AkkermanTheo J M Verheij
Jul 30, 2005·Journal of General Internal Medicine·Christianne L RoumieMarie R Griffin
Aug 6, 2005·BMJ : British Medical Journal·Paul Little
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Didier GuillemotClaude Carbon
Oct 20, 2005·The Cochrane Database of Systematic Reviews·S R Arnold, S E Straus
Mar 29, 2006·European Journal of Clinical Pharmacology·Herman GoossensPeter G Davey
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ulla-Maija RautakorpiUNKNOWN MIKSTRA Collaborative Study Group
Apr 7, 2006·The New England Journal of Medicine·Moe H KyawUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Apr 21, 2006·The Cochrane Database of Systematic Reviews·G JamtvedtA D Oxman
May 18, 2006·Emerging Infectious Diseases·Larissa GrigoryanJoan Birkin
May 20, 2006·La Presse médicale·Pascale Bruno-BazureaultUNKNOWN pour le Groupe d'étude et de prévention des infections de l'enfant (GEPIE)
Sep 6, 2006·Archives of Pediatrics & Adolescent Medicine·Rita Mangione-SmithJohn Heritage
Sep 28, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vilhjalmur A ArasonKarl G Kristinsson

❮ Previous
Next ❯

Citations

Jul 7, 2010·International Journal of Public Health·Giuliano MasieroHerman Goossens
Oct 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F AngoulvantC Alberti
Aug 14, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F DusemundUNKNOWN ProREAL Study Team
Jun 19, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·M FilippiniG Masiero
Nov 9, 2011·Journal of General Internal Medicine·Lucy Brookes-HowellChristopher C Butler
May 25, 2010·The Journal of Antimicrobial Chemotherapy·Attila AltinerJürgen In der Schmitten
Oct 20, 2010·The Journal of Antimicrobial Chemotherapy·Donna M LeckyUNKNOWN e-Bug Working Group
Aug 9, 2011·The Journal of Antimicrobial Chemotherapy·Cliodna A M McNultyUNKNOWN e-Bug Working Group
Jun 28, 2011·The Journal of Antimicrobial Chemotherapy·Niels AdriaenssensHerman Goossens
Jan 11, 2012·Antimicrobial Agents and Chemotherapy·Anna K StuckKathrin Mühlemann
Jan 13, 2011·BMC Family Practice·Ingeborg BjörkmanCecilia Stålsby Lundborg
Sep 11, 2012·Antimicrobial Resistance and Infection Control·Jean CarletUNKNOWN Participants of the 3rd World Healthcare-Associated Infections Forum
Sep 17, 2013·International Journal of Environmental Research and Public Health·Chang-Ro LeeSang Hee Lee
Dec 15, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Naomi StantonChris C Butler
May 31, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sarah Tonkin-CrinePaul Little
Dec 6, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Alike W van der VeldenTheo J M Verheij
May 7, 2015·BioMed Research International·Chang-Ro LeeSang Hee Lee
Feb 22, 2014·BMC Pharmacology & Toxicology·Do Thi Thuy NgaHeiman F L Wertheim
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lauri A HicksUNKNOWN Active Bacterial Core Surveillance (ABCs) Team
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benedikt Huttner, Matthew Samore
Feb 11, 2014·The Journal of Antimicrobial Chemotherapy·Joep van den Broek d'ObrenanAlike W van der Velden
Nov 8, 2013·Drug and Therapeutics Bulletin
Jul 16, 2014·The Lancet Infectious Diseases·Thomas P Van BoeckelRamanan Laxminarayan
Nov 30, 2014·BMC Infectious Diseases·Jean CarletCéline Pulcini
Mar 4, 2014·Computational and Mathematical Methods in Medicine·Kieran S O'BrienThomas M Lietman
Jan 21, 2014·The Lancet Infectious Diseases·Benedikt Huttner
Oct 16, 2013·Antimicrobial Agents and Chemotherapy·Adeline BernierLaurence Watier
Sep 18, 2013·The Journal of Antimicrobial Chemotherapy·Donna M Lecky, Cliodna A M McNulty
Mar 31, 2015·Expert Review of Anti-infective Therapy·Rabiatul Salmi Md RezalBrian Godman
May 23, 2015·European Journal of Clinical Pharmacology·Jakob HolstiegeEdeltraut Garbe
Sep 18, 2015·The Journal of Antimicrobial Chemotherapy·D Ashiru-Oredope, S Hopkins
Apr 29, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Laura J ShallcrossSally C Davies

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved